Fosfomycin Tromethamine

CHEMBL1200331 Phase 4 승인됨 Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
259.2 g/mol
LogP
Phase
4

This tromethamine salt form of fosfomycin is an oral antibiotic taken as a single dose to treat uncomplicated urinary tract infections. Its unique mechanism of action, inhibiting early cell wall synthesis, makes it effective against many common urinary pathogens including resistant strains.

분자량

259.1900 g/mol

TPSA

157.00 Ų

치료 영역

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D 구조

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

C[C@@H]1O[C@@H]1P(=O)(O)O.NC(CO)(CO)CO

InChI

InChI=1S/C4H11NO3.C3H7O4P/c5-4(1-6,2-7)3-8;1-2-3(7-2)8(4,5)6/h6-8H,1-3,5H2;2-3H,1H3,(H2,4,5,6)/t;2-,3+/m.0/s1

Molecular Formula

C7H18NO7P

HBD / HBA

6 / 8

회전 가능 결합

4

무거운 원자

16

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

자주 묻는 질문

This tromethamine salt form of fosfomycin is an oral antibiotic taken as a single dose to treat uncomplicated urinary tract infections. Its unique mechanism of action, inhibiting early cell wall synthesis, makes it effective against many common urinary pathogens including resistant strains.

Yes, Fosfomycin Tromethamine is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1200331. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 10199068. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

의학적 면책조항

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.